Pitavastatin (Livazo®)

Assessment Status Rapid Review Complete
Drug Pitavastatin
Brand Livazo®
Indication Is indicated for the reduction of elevated TC and LDL-C, in adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia and combined (mixed) dyslipidaemia, when response to diet and other non-pharmacological measures are inadequate.
Assessment Process
Rapid review commissioned 22/12/2010
Rapid review completed 24/12/2010
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended